General Introduction

The medicine production domain can certainly be mechanical and concerned, but it means nothing if our work is so unclear as to be confusing. API (Active Pharmaceutical ingredient) and FDI (Finished dosage form) are frequently used in the pharmaceutical sector. They are used for products of pharmaceuticals. However, the terms are quite common for people associated with the pharma industry but understanding these terminologies or abbreviations will be difficult for common people. To enlighten people about these concepts, here we proceed with this blog.

Let us discuss the difference between FDF and API and how these two pieces of the pharmaceutical formulation process are interconnected.

Finished Dosage Form (FDI)

This term is used to refer to the actual finalized drug product that is ready for consumption. FDs have various forms, including solid tablets, hard gelatin capsules, soft gelatin capsules, powder in sachets, liquid solutions like syrups, etc. It is important to know that they usually contain an API and various inactive ingredients. Therefore, if we see technically, FDF refers to the physical form of the drug produced for sale at any pharmacy where customers shop.

Active Pharmaceutical Ingredient (API)

As the term suggests, API is the component or element of the drug that acts the intended effect on the customer’s body. APIs need inactive ingredients to improve taste, the ability to swallow, provide a smooth coating, and support the actual drug delivery. For example, acetaminophen is the active ingredient in a whole host of over-the-counter pain relief medications. API is the opposite of inactive ingredients and is required essentially in drug preparation, but they generally do not affect the condition the customer is trying to change. Coloring used in medicines is an example of an inactive ingredient; although they play no role in drug making but can have side effects on the body.

Connectivity

Both terms refer to pharmaceutical formulations, which are completely different from each other but are indivisible when developing and producing pharmaceuticals.

Akums Drugs and Pharmaceuticals Ltd.

Akums is India’s only biggest Contract Research and Manufacturing (CRAMS) organization, accountable for manufacturing 12 % of all drugs consumed in the country. They are the best-known contract manufacturers of pharmaceuticals in India. Akums 10 state-of-the-art facilities are prepared to create all modern dosage forms like tablets, hard gelatin capsules, soft gelatin capsules, powder in sachets, liquid syrups, etc., with huge production capacity. The processes run from drug development through commercialization exclusively in the area of formulation, in which drugs are prepared from active ingredients using vital means. It has the experience and operational strength to work on both proficiently.